You searched for: jintwerew (Maltesiska - Engelska)

il-kostijiet medji mhux qed jintwerew.
the average costs are not shown.

ir-riżultati se jintwerew f'göteborg.
the results will be revealed in göteborg.

eżempji oħrajn jintwerew fl-anness iii.
further examples areshownin annex iii.

ir-riżultati qed jintwerew f'tabella 4.
results are shown in table 4.

risponsi għal imbruvica qed jintwerew f’tabella 2.
responses to imbruvica are shown in table 2.

jintwerew grazzi għal eżempji konkreti ta' implimentazzjoni:
they are illustrated by specific examples of application:

dejta tar- rispons qed jintwerew f’ tabella 3.
major cytogenetic response, haematological response, molecular response (evaluation of minimal residual disease), time to accelerated phase or blast crisis and survival are main secondary endpoints.

fejn xieraq li jintwerew sinjali tal-perikolu bijoloġiku;
where appropriate to display biohazard signs;

karatteristiċi fil-linja bażi qed jintwerew f’tabella 5.
baseline characteristics are shown in table 5.

(l-operazzjonijiet ġodda qed jintwerew b’tipa grassa)
(new operations are shown in bold)

ir-riżultati tal-effikaċja qed jintwerew fit-tabella 3.
efficacy results are shown in table 3.

ir-reazzjonijiet avversi osservati qed jintwerew fit-tabella hawn taħt.
the adverse reactions observed are shown in the table below.

(eżempju: qed jintwerew 12 unità fit-tieqa tad- doża)
(example: 12 units shown in the dose window)

(c) jiġu eliminati perikoli mhux elettriċi li jintwerew mill-esperjenza;
eliminate non-electrical dangers which are revealed by experience;

il-kurvi kaplan-meier għal os qed jintwerew f’figura 1.
the kaplan-meier curves for os are shown in figure 1.

ir-riżultati ewlenin tal-effikaċja qed jintwerew f’tabella 6 hawn taħt.
the key efficacy results are shown in table 6 below.

(eżempju: qed jintwerew 12-il unità fit-tieqa tad- doża)
(example: 12 units shown in the dose window)

il-kurvi kaplan-meier għall-os qed jintwerew fil-figura 1.
the kaplan-meier curves for os are shown in figure 1.

ir-riżultati ta’ effikaċja għall-istudju cll3001qed jintwerew f’tabella 7.
efficacy results for study cll3001 are shown in table 7.

il-pazjenti għandhom jintwerew istruzzjonijiet kif għandhom jamministraw il-prodott b’mod korrett.
patients should be instructed on how to administer the product correctly.